[PTGX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
04-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -95.82%
YoY- -31.74%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 0 0 0 859 25,722 8,617 10,286 -
PBT -33,725 -34,194 -31,232 -41,037 -20,930 -36,907 -33,804 -0.15%
Tax -2,296 -2,909 -1,071 -406 -181 -832 122 -
NP -31,429 -31,285 -30,161 -40,631 -20,749 -36,907 -33,804 -4.74%
Tax Rate - - - - - - - -
Total Cost 31,429 31,285 30,161 41,490 46,471 45,524 44,090 -20.21%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.00 0.00 0.00 -4,730.03 -80.67 -428.30 -328.64 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.62 -0.64 -0.62 -0.83 -0.43 -0.77 -0.70 -7.77%
EPS Diluted -0.62 -0.64 -0.61 -0.83 -0.43 -0.77 -0.70 -7.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.